| Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ... Neurology 89 (11), 1117-1126, 2017 | 275 | 2017 |
| Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ... Neurology 89 (11), 1107-1116, 2017 | 229 | 2017 |
| Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in‐frame deletion in CCM2 prevents formation of a CCM1/CCM2 … S Stahl, S Gaetzner, K Voss, B Brackertz, E Schleider, O Sürücü, E Kunze, ... Human mutation 29 (5), 709-717, 2008 | 122 | 2008 |
| Diagnosis and classification of optic neuritis A Petzold, CL Fraser, M Abegg, R Alroughani, D Alshowaeir, R Alvarenga, ... The Lancet Neurology 21 (12), 1120-1134, 2022 | 93 | 2022 |
| Incidence, seasonality and comorbidity in vestibular neuritis I Adamec, M Krbot Skorić, J Handžić, M Habek Neurological sciences 36, 91-95, 2015 | 93 | 2015 |
| Isolated cranial nerve palsies in multiple sclerosis I Zadro, B Barun, M Habek, VV Brinar Clinical neurology and neurosurgery 110 (9), 886-888, 2008 | 93 | 2008 |
| Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness: Consensus statement of … RD Thijs, M Brignole, C Falup-Pecurariu, A Fanciulli, R Freeman, ... Autonomic Neuroscience 233, 102792, 2021 | 86 | 2021 |
| Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study DH Miller, RJ Fox, JT Phillips, M Hutchinson, E Havrdova, M Kita, ... Neurology 84 (11), 1145-1152, 2015 | 81 | 2015 |
| Nutrition in multiple sclerosis M Habek, I Hojsak, VV Brinar Clinical Neurology and Neurosurgery 112 (7), 616-620, 2010 | 77 | 2010 |
| Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months S De Mercanti, S Rolla, A Cucci, V Bardina, E Cocco, A Vladic, ... Neuroimmunology & Neuroinflammation 3 (1), e194, 2016 | 76 | 2016 |
| Autonomic dysfunction in multiple sclerosis I Adamec, M Habek Clinical Neurology and Neurosurgery 115, S73-S78, 2013 | 73 | 2013 |
| Long‐term safety and efficacy of Eculizumab in Aquaporin‐4 IgG‐positive NMOSD DM Wingerchuk, K Fujihara, J Palace, A Berthele, M Levy, HJ Kim, ... Annals of neurology 89 (6), 1088-1098, 2021 | 70 | 2021 |
| Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients G Giovannoni, JA Cohen, AJ Coles, HP Hartung, E Havrdova, KW Selmaj, ... Neurology 87 (19), 1985-1992, 2016 | 66 | 2016 |
| The vestibular evoked myogenic potentials (VEMP) score: a promising tool for evaluation of brainstem involvement in multiple sclerosis T Gabelić, M Krbot Skorić, I Adamec, B Barun, I Zadro, M Habek European Journal of Neurology 22 (2), 261-e21, 2015 | 61 | 2015 |
| Isolated hypoglossal nerve palsy: a diagnostic challenge M Boban, VV Brinar, M Habek, M Rados European neurology 58 (3), 177, 2007 | 59 | 2007 |
| Ocular and cervical vestibular evoked myogenic potentials in patients with multiple sclerosis T Gabelic, M Krbot, AB Šefer, V Išgum, I Adamec, M Habek Journal of clinical neurophysiology 30 (1), 86-91, 2013 | 58 | 2013 |
| Postprandial hypotension in neurological disorders: systematic review and meta-analysis A Pavelić, M Krbot Skorić, L Crnošija, M Habek Clinical Autonomic Research 27, 263-271, 2017 | 56 | 2017 |
| Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis M Habek, L Crnošija, M Lovrić, A Junaković, M Krbot Skorić, I Adamec Clinical autonomic research 26, 385-393, 2016 | 56 | 2016 |
| The differential diagnosis of acute transverse myelitis VV Brinar, M Habek, M Brinar, B Malojčić, M Boban Clinical neurology and neurosurgery 108 (3), 278-283, 2006 | 55 | 2006 |
| Auditory evoked potentials and vestibular evoked myogenic potentials in evaluation of brainstem lesions in multiple sclerosis A Ivanković, VN Mađarić, K Starčević, MK Skorić, T Gabelić, I Adamec, ... Journal of the neurological sciences 328 (1-2), 24-27, 2013 | 53 | 2013 |
